improved glycaemic control
, which resulted in the need to reduce the dose of glibenclamide (glyburide
) or glipizide
in almost half of the patients in one study. In other studies, orlistat
reduced the dose requirement for metformin
Monitor the outcome of concurrent use on blood sugar levels and adjust the antidiabetic treatment accordingly.